TIVERTON ASSET MANAGEMENT LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
TIVERTON ASSET MANAGEMENT LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$1,059,000
-23.4%
7,5500.0%0.04%
-24.5%
Q2 2019$1,382,000
+15.5%
7,550
+0.4%
0.05%
-5.8%
Q1 2019$1,197,000
+101.5%
7,523
+21.3%
0.05%
+44.4%
Q4 2018$594,000
-35.4%
6,200
-4.7%
0.04%
-20.0%
Q3 2018$919,000
+301.3%
6,506
+345.0%
0.04%
+275.0%
Q2 2018$229,0001,4620.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders